Clinical Trial Update: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely [Phase 2]

View source ↗

Summary

Phase 2 trial of merotocin in mothers with inadequate milk production and preterm-delivered infants; the study was terminated with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inadequate Milk Production
• Preterm Delivery

Drugs mentioned

• merotocin

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Preterm Delivery, Inadequate Milk Production | Phase 2 | Status: TERMINATED | Results posted: 2024-02-07